134 related articles for article (PubMed ID: 3263486)
1. Postvaccination susceptibility to invasive Haemophilus influenzae type b disease in infant rats.
Sood SK; Schreiber JR; Siber GR; Daum RS
J Pediatr; 1988 Nov; 113(5):814-9. PubMed ID: 3263486
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
[TBL] [Abstract][Full Text] [Related]
3. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
4. Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine.
Marchant CD; Band E; Froeschle JE; McVerry PH
Pediatr Infect Dis J; 1989 Aug; 8(8):508-11. PubMed ID: 2788860
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.
Madore DV; Johnson CL; Phipps DC; Myers MG; Eby R; Smith DH
Pediatrics; 1990 Oct; 86(4):527-34. PubMed ID: 2216616
[TBL] [Abstract][Full Text] [Related]
6. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
Santosham M; Wolff M; Reid R; Hohenboken M; Bateman M; Goepp J; Cortese M; Sack D; Hill J; Newcomer W
N Engl J Med; 1991 Jun; 324(25):1767-72. PubMed ID: 1903846
[TBL] [Abstract][Full Text] [Related]
7. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of disease due to Haemophilus influenzae type b occurring in vaccinated children.
Hiner EE; Frasch CE
J Infect Dis; 1988 Aug; 158(2):343-8. PubMed ID: 3261314
[TBL] [Abstract][Full Text] [Related]
9. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1985 Apr; 34(15):201-5. PubMed ID: 3920487
[No Abstract] [Full Text] [Related]
10. Haemophilus influenzae b polysaccharide revaccination: a continued role for the unconjugated vaccine.
Pichichero ME; Bracikowski A; Sullivan R; Madore D; Anderson P
Pediatr Infect Dis J; 1989 Jan; 8(1):20-3. PubMed ID: 2784202
[TBL] [Abstract][Full Text] [Related]
11. Maternal immunization with the capsular polysaccharide vaccine for Haemophilus influenzae type b.
Glezen WP; Englund JA; Siber GR; Six HR; Turner C; Shriver D; Hinkley CM; Falcao O
J Infect Dis; 1992 Jun; 165 Suppl 1():S134-6. PubMed ID: 1588147
[TBL] [Abstract][Full Text] [Related]
12. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.
Peltola H; Käyhty H; Sivonen A; Mäkelä H
Pediatrics; 1977 Nov; 60(5):730-7. PubMed ID: 335348
[TBL] [Abstract][Full Text] [Related]
13. Conjugated Haemophilus influenzae type b vaccine.
Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400
[No Abstract] [Full Text] [Related]
14. Decline in serum antibody to the capsule of Haemophilus influenzae type b in the immediate postimmunization period.
Daum RS; Sood SK; Osterholm MT; Pramberg JC; Granoff PD; White KE; Granoff DM
J Pediatr; 1989 May; 114(5):742-7. PubMed ID: 2785591
[TBL] [Abstract][Full Text] [Related]
15. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM
J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
Eskola J; Peltola H; Takala AK; Käyhty H; Hakulinen M; Karanko V; Kela E; Rekola P; Rönnberg PR; Samuelson JS
N Engl J Med; 1987 Sep; 317(12):717-22. PubMed ID: 3306379
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB).
Vella PP; Staub JM; Armstrong J; Dolan KT; Rusk CM; Szymanski S; Greer WE; Marburg S; Kniskern PJ; Schofield TL
Pediatrics; 1990 Apr; 85(4 Pt 2):668-75. PubMed ID: 2107517
[TBL] [Abstract][Full Text] [Related]
18. Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom.
Tudor-Williams G; Frankland J; Isaacs D; Mayon-White RT; MacFarlane JA; Rees DG; Moxon ER
Arch Dis Child; 1989 Apr; 64(4):520-4. PubMed ID: 2665657
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of human hyperimmune globulin in prevention of Haemophilus influenzae type b disease in infant rats.
Ambrosino D; Schreiber JR; Daum RS; Siber GR
Infect Immun; 1983 Feb; 39(2):709-14. PubMed ID: 6601060
[TBL] [Abstract][Full Text] [Related]
20. Lack of efficacy of Haemophilus b polysaccharide vaccine in Minnesota.
Osterholm MT; Rambeck JH; White KE; Jacobs JL; Pierson LM; Neaton JD; Hedberg CW; MacDonald KL; Granoff DM
JAMA; 1988 Sep; 260(10):1423-8. PubMed ID: 3261350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
